VERA Q4 2025 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$1M

Operating Income

-$94M

Net Income

-$91M

EPS (Diluted)

$-1.39

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$70M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$735M

Total Liabilities

$130M

Stockholders' Equity

$605M

Cash & Equivalents

$355M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$94M	-$49M	-92.6%
Net Income	-$91M	-$43M	-109.8%